TY - JOUR
T1 - Surgical aortic valve replacement with new-generation bioprostheses: Sutureless versus rapid-deployment
AU - D'Onofrio, Augusto
AU - D'Onofrio, Ginevra Federica
AU - Salizzoni, Stefano
AU - Filippini, Claudia
AU - Tessari, Chiara
AU - Bagozzi, Lorenzo
AU - Messina, Antonio
AU - Troise, Giovanni
AU - Tomba, Margerita Dalla
AU - Rambaldini, Manfredo
AU - Dalén, Magnus
AU - Alamanni, Francesco
AU - Massetti, Massimo
AU - Mignosa, Carmelo
AU - Russo, Claudio
AU - Salvador, Loris
AU - Di Bartolomeo, Roberto
AU - Maselli, Daniele
AU - De Paulis, Ruggero
AU - Alfieri, Ottavio
AU - De Filippo, Carlo Maria
AU - Portoghese, Michele
AU - Bortolotti, Uberto
AU - Rinaldi, Mauro
AU - Gerosa, Gino
PY - 2020
Y1 - 2020
N2 - Objectives: The aim of this retrospective multicenter study was to compare early clinical and hemodynamic outcomes of Perceval-S sutureless (Livanova, London, United Kingdom) and Intuity rapid-deployment (Edwards Lifesciences, Irvine, Calif) bioprostheses. Methods: Data from patients who underwent isolated or combined aortic valve replacement with Perceval-S and with Intuity bioprostheses at 18 cardiac surgical institutions were analyzed. Propensity matching was performed to identify similar patient cohorts. Results: We included 911 patients from March 2011 until May 2017. Perceval-S and Intuity valves were implanted in 349 (38.3%) and in 562 (61.7%) patients, respectively. Propensity score identified 117 matched pairs. In the matched cohort, device success was 99.1% and 100% in Perceval-S and Intuity group, respectively (P = 1.000). Thirty-day Valve Academic Research Consortium mortality occurred in 2 (1.7%) and 4 (3.4%) patients in the Perceval-S and in Intuity group, respectively (P = .6834). The rate of postoperative new permanent pacemaker implantation was 6% (7 patients) and 6.8% (8 patients) in the Perceval-S and in Intuity group, respectively (P = .7896). Perceval-S valve implantation requires significantly shorter aortic crossclamp and cardiopulmonary bypass times than Intuity valve implantation (aortic crossclamp time for isolated, 52 ± 14 minutes vs 62 ± 24 minutes; P < .0001). Peak transaortic gradients were 22.4 ± 8.1 mm Hg and 19.6 ± 6.7 mm Hg (P = .0144), whereas mean gradients were 11.8 ± 4.7 mm Hg and 10.5 ± 3.9 mm Hg (P = .0388) in the Perceval-S and Intuity groups, respectively. Conclusions: Sutureless Perceval-S and rapid-deployment Intuity bioprostheses provide good and similar early clinical and hemodynamic outcomes. Perceval-S valve implantation requires shorter crossclamp and cardiopulmonary bypass times, whereas Intuity valve implantation provides lower transaortic peak and mean gradients.
AB - Objectives: The aim of this retrospective multicenter study was to compare early clinical and hemodynamic outcomes of Perceval-S sutureless (Livanova, London, United Kingdom) and Intuity rapid-deployment (Edwards Lifesciences, Irvine, Calif) bioprostheses. Methods: Data from patients who underwent isolated or combined aortic valve replacement with Perceval-S and with Intuity bioprostheses at 18 cardiac surgical institutions were analyzed. Propensity matching was performed to identify similar patient cohorts. Results: We included 911 patients from March 2011 until May 2017. Perceval-S and Intuity valves were implanted in 349 (38.3%) and in 562 (61.7%) patients, respectively. Propensity score identified 117 matched pairs. In the matched cohort, device success was 99.1% and 100% in Perceval-S and Intuity group, respectively (P = 1.000). Thirty-day Valve Academic Research Consortium mortality occurred in 2 (1.7%) and 4 (3.4%) patients in the Perceval-S and in Intuity group, respectively (P = .6834). The rate of postoperative new permanent pacemaker implantation was 6% (7 patients) and 6.8% (8 patients) in the Perceval-S and in Intuity group, respectively (P = .7896). Perceval-S valve implantation requires significantly shorter aortic crossclamp and cardiopulmonary bypass times than Intuity valve implantation (aortic crossclamp time for isolated, 52 ± 14 minutes vs 62 ± 24 minutes; P < .0001). Peak transaortic gradients were 22.4 ± 8.1 mm Hg and 19.6 ± 6.7 mm Hg (P = .0144), whereas mean gradients were 11.8 ± 4.7 mm Hg and 10.5 ± 3.9 mm Hg (P = .0388) in the Perceval-S and Intuity groups, respectively. Conclusions: Sutureless Perceval-S and rapid-deployment Intuity bioprostheses provide good and similar early clinical and hemodynamic outcomes. Perceval-S valve implantation requires shorter crossclamp and cardiopulmonary bypass times, whereas Intuity valve implantation provides lower transaortic peak and mean gradients.
KW - aortic valve
KW - rapid deployment aortic bioprosthesis
KW - replacement
KW - sutureless aortic bioprosthesis
KW - aortic valve
KW - rapid deployment aortic bioprosthesis
KW - replacement
KW - sutureless aortic bioprosthesis
UR - http://hdl.handle.net/10807/146182
UR - http://www.elsevier.com/inca/publications/store/6/2/3/1/5/1/index.htt
U2 - 10.1016/j.jtcvs.2019.02.135
DO - 10.1016/j.jtcvs.2019.02.135
M3 - Article
SN - 0022-5223
VL - 159
SP - 432
EP - 442
JO - The Journal of thoracic surgery
JF - The Journal of thoracic surgery
ER -